Mechanisms of endogenous retrovirus-mediated antiviral immunity against genital herpes simplex virus 2 infection and disease.
Mechanisms of endogenous retrovirus-mediated antiviral immunity against genital herpes simplex virus 2 infection and disease.
内源性逆转录病毒介导的针对生殖器单纯疱疹病毒2感染和疾病的抗病毒免疫机制。
批准号：
463342
负责人：
Tokuyama Maria
金额：
$59.91万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2027-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Herpes simplex virus 2 (HSV-2) is a sexually transmitted virus that affects over 500 million individuals worldwide. HSV-2 establishes a life-long infection with the host and causes lesions, pain, and discomfort in the female genital tract that persists fo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing a novel vaccine against herpes simplex virus 2
-
批准号：488762
-
项目类别：Operating Grants
-
资助金额：$7.26万
-
财政年份：2023
-
负责人：Tokuyama Maria
-
依托单位：
Prize 202203PJT - Mechanisms of endogenous retrovirus-mediated antiviral immunity against genital herpes simplex virus 2 infection and disease.
-
批准号：467989
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2022
-
负责人：Tokuyama Maria
-
依托单位：
海外基金
